Tempus provides technology, genomic testing, data, and AI solutions for healthcare, research, and life sciences applications.
Tempus has raised $9.5M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Tempus's investors include New Enterprise Associates, Ares Management, T. Rowe Price, Franklin Templeton, Novo Holdings.
Tempus is headquartered in Chicago, United States.
Tempus provides technology, genomic testing, data, and AI solutions for healthcare, research, and life sciences applications.
Tempus is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tempus — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/tempus-chicago. Accessed October 21, 2026.
VCBacked. (2026). Tempus — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/tempus-chicago
{{cite web |title=Tempus — Funding & Investors |url=https://www.vcbacked.co/company/tempus-chicago |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated